Theratechnologies Resumes Distribution of EGRIFTA(R) (Tesamorelin for Injection) in the United States
Marketwire - Wed Sep 03, 5:18PM CDT
Theratechnologies Inc. (TSX: TH) is pleased to announce that a first shipment of EGRIFTA(R) (tesamorelin for injection) was sent to its U.S.-based wholesale distributor in order to replenish the supply chain. As a consequence, EGRIFTA(R) will once again be available to patients in the United States by mid-September, as planned.
Theratechnologies Announces Financial Results for Second Quarter of 2014
Marketwire - Wed Jul 09, 5:45AM CDT
Theratechnologies Inc. (Theratechnologies) (TSX: TH) today announced its financial results for the second quarter ended May 31, 2014.
Theratechnologies to Announce Financial Results for the Second Quarter of 2014
Marketwire - Wed Jul 02, 3:20PM CDT
Theratechnologies Inc. (TSX: TH) (Theratechnologies) announced today that it will issue its financial results for the second quarter ended May 31, 2014, on Wednesday, July 9, 2014, before markets open.
IIROC Trade Halt - Theratechnologies Inc.
Newsfile Corp - Wed Jun 25, 8:23AM CDT
The following issues have been halted by IIROC:
IIROC Trade Resumption - Theratechnologies Inc.
Newsfile Corp - Wed Jun 25, 8:17AM CDT
Trading resumes in:
Theratechnologies to Receive 4.1 Million Dollar Payment from Revenue Canada
Marketwire - Wed Jun 25, 8:05AM CDT
Theratechnologies Inc. (Theratechnologies) (TSX: TH) today announced that it will receive a refund of approximately $4.1 million from the Canada Revenue Agency after settling a dispute over its claims of refundable investment tax credits related to its 1994 and 1995 taxation years.
Theratechnologies Announces Financial Results for Fiscal Year 2013
Marketwire - Thu Feb 27, 6:02AM CST
Theratechnologies Inc. (Theratechnologies) (TSX: TH) today announced its financial results for the year ended November 30, 2013.
Theratechnologies to Announce Financial Results for Fiscal Year 2013
Marketwire - Tue Feb 25, 4:01PM CST
Theratechnologies Inc. (TSX: TH) (Theratechnologies) announced today that it will issue its financial results for the fiscal year ended November 30, 2013, on Thursday, February 27, 2014, before markets open.
Theratechnologies Inc.: Short Supply of EGRIFTA(R) Announced
Marketwire - Fri Feb 14, 5:01AM CST
Theratechnologies Inc. (TSX: TH) announced today that it expects current inventory of EGRIFTA(R) (tesamorelin for injection) to be depleted in the coming weeks due to a combination of manufacturing delays and issues observed during the production of new batches of EGRIFTA(R). The depletion of the inventory will result in a shortage of EGRIFTA(R) and an eventual stock-out. EMD Serono, Inc. has notified the United States Food and Drug Administration about this product shortage.
EMD Serono Notifies FDA of a Shortage of Tesamorelin
Marketwire - Wed Sep 18, 4:38PM CDT
Theratechnologies Inc. (TSX: TH) announced today that EMD Serono voluntarily notified the United States Food and Drug Administration (FDA) about an upcoming shortage of tesamorelin in the United States.
Theratechnologies Provides Manufacturing Update on EGRIFTA(TM)
Marketwire - Wed Sep 04, 4:22PM CDT
Theratechnologies Inc. (TSX: TH) announced today that it will resume production of EGRIFTA(TM) using its original manufacturing process (original process).